Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jul 1;11(7):1875. doi: 10.3390/biomedicines11071875

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

A summary of the beneficial effects of tirzepatide across the spectrum of metabolic diseases (T2D, obesity and NAFLD). BW: body weight; FPG: fasting plasma glucose; GIPR: glucose-dependent insulinotropic polypeptide receptor; GLP-1R: glucagon-like peptide-1 receptor; HbA1c: haemoglobin A1c; LFC: liver fat content; NAFLD: non-alcoholic fatty liver disease; PPG: postprandial glucose; SAT: subcutaneous adipose tissue; T2D: type 2 diabetes; TAR: time above range; TBR: time below range; TIR: time in range; VAT: visceral adipose tissue; WC: waist circumference.